AllianceBernstein’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $43.1K | Buy |
+11,580
| New | +$58.3K | ﹤0.01% | 3302 |
|
|
2023
Q2 | – | Sell |
-20,500
| Closed | -$77.4K | – | 3209 |
|
|
2023
Q1 | $77.4K | Buy |
20,500
+1,100
| +6% | +$6.13K | ﹤0.01% | 3050 |
|
|
2022
Q4 | $126K | Buy |
19,400
+700
| +4% | +$5.77K | ﹤0.01% | 3091 |
|
|
2022
Q3 | $166K | Buy |
18,700
+600
| +3% | +$6.1K | ﹤0.01% | 3054 |
|
|
2022
Q2 | $180K | Hold |
18,100
| – | – | ﹤0.01% | 3044 |
|
|
2022
Q1 | $210K | Buy |
18,100
+100
| +0.6% | +$1.11K | ﹤0.01% | 2982 |
|
|
2021
Q4 | $200K | Sell |
18,000
-1,300
| -7% | -$12.6K | ﹤0.01% | 3075 |
|
|
2021
Q3 | $178K | Sell |
19,300
-900
| -4% | -$9.79K | ﹤0.01% | 3108 |
|
|
2021
Q2 | $227K | Sell |
20,200
-3,700
| -15% | -$42.7K | ﹤0.01% | 3120 |
|
|
2021
Q1 | $253K | Sell |
23,900
-7,900
| -25% | -$88.8K | ﹤0.01% | 2972 |
|
|
2020
Q4 | $345K | Sell |
31,800
-10,701
| -25% | -$111K | ﹤0.01% | 2788 |
|
|
2020
Q3 | $413K | Sell |
42,501
-859
| -2% | -$8.18K | ﹤0.01% | 2630 |
|
|
2020
Q2 | $345K | Buy |
43,360
+14,060
| +48% | +$145K | ﹤0.01% | 2819 |
|
|
2020
Q1 | $255K | Buy |
29,300
+2,500
| +9% | +$26K | ﹤0.01% | 2699 |
|
|
2019
Q4 | $303K | Hold |
26,800
| – | – | ﹤0.01% | 2772 |
|
|
2019
Q3 | $291K | Buy |
26,800
+2,800
| +12% | +$30.5K | ﹤0.01% | 2815 |
|
|
2019
Q2 | $225K | Buy |
24,000
+3,815
| +19% | +$38.5K | ﹤0.01% | 2926 |
|
|
2019
Q1 | $248K | Buy |
20,185
+2,485
| +14% | +$30.3K | ﹤0.01% | 2832 |
|
|
2018
Q4 | $210K | Buy |
17,700
+900
| +5% | +$12.4K | ﹤0.01% | 2872 |
|
|
2018
Q3 | $242K | Hold |
16,800
| – | – | ﹤0.01% | 2924 |
|
|
2018
Q2 | $250K | Sell |
16,800
-500
| -3% | -$6.95K | ﹤0.01% | 2878 |
|
|
2018
Q1 | $226K | Buy |
17,300
+1,600
| +10% | +$21K | ﹤0.01% | 2800 |
|
|
2017
Q4 | $198K | Sell |
15,700
-500
| -3% | -$6.32K | ﹤0.01% | 2874 |
|
|
2017
Q3 | $210K | Hold |
16,200
| – | – | ﹤0.01% | 2915 |
|
|
2017
Q2 | $241K | Buy |
+16,200
| New | +$226K | ﹤0.01% | 2910 |
|
|
2015
Q2 | – | Sell |
-5,800
| Closed | -$81K | – | 3158 |
|
|
2015
Q1 | $81K | Sell |
5,800
-700
| -11% | -$9.67K | ﹤0.01% | 3052 |
|
|
2014
Q4 | $90K | Sell |
6,500
-1,800
| -22% | -$23.3K | ﹤0.01% | 3009 |
|
|
2014
Q3 | $102K | Sell |
8,300
-5,100
| -38% | -$63.7K | ﹤0.01% | 2962 |
|
|
2014
Q2 | $167K | Sell |
13,400
-7,145
| -35% | -$84.1K | ﹤0.01% | 2867 |
|
|
2014
Q1 | $229K | Sell |
20,545
-2,900
| -12% | -$31.8K | ﹤0.01% | 2718 |
|
|
2013
Q4 | $284K | Sell |
23,445
-5,200
| -18% | -$62.1K | ﹤0.01% | 2684 |
|
|
2013
Q3 | $349K | Sell |
28,645
-70
| -0.2% | -$977 | ﹤0.01% | 2657 |
|
|
2013
Q2 | $379K | Buy |
+28,715
| New | +$397K | ﹤0.01% | 2621 |
|
Other funds holding LFCR
WC
LPAM
GRIM
3C
QOP
AllianceBernstein's LFCR Position: Q2 2026 in Review
AllianceBernstein opened a new position in Lifecore Biomedical (LFCR) in Q2 2026: 11,580 shares worth $43.1K. The stake represents ﹤0.01% of the portfolio and ranks #3302 among its holdings. This is a return to the name: AllianceBernstein previously reported a position in LFCR as recently as Q1 2023.
AllianceBernstein first reported a position in LFCR in Q2 2013 and has held it in 33 quarters since. The position peaked at $413K in Q3 2020. 99 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.
- AllianceBernstein held 11,580 shares of Lifecore Biomedical worth $43.1K as of Q2 2026.
- Lifecore Biomedical was a new AllianceBernstein position in Q2 2026.
- Lifecore Biomedical made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #3302 holding.
- AllianceBernstein first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 33 quarters since.
- AllianceBernstein's Lifecore Biomedical position peaked at $413K in Q3 2020.
- 99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.